Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5191596
Max Phase: Preclinical
Molecular Formula: C32H50N6O10
Molecular Weight: 678.78
Associated Items:
ID: ALA5191596
Max Phase: Preclinical
Molecular Formula: C32H50N6O10
Molecular Weight: 678.78
Associated Items:
Canonical SMILES: CCCCCCCCOC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](OCc2ccccc2)[C@@H]1N=[N+]=[N-])C(N)=O
Standard InChI: InChI=1S/C32H50N6O10/c1-4-5-6-7-8-12-17-45-25(40)16-15-23(29(33)42)36-30(43)20(2)35-31(44)21(3)47-28-26(37-38-34)32(48-24(18-39)27(28)41)46-19-22-13-10-9-11-14-22/h9-11,13-14,20-21,23-24,26-28,32,39,41H,4-8,12,15-19H2,1-3H3,(H2,33,42)(H,35,44)(H,36,43)/t20-,21+,23+,24+,26+,27+,28+,32-/m0/s1
Standard InChI Key: YDYJRWYKYGMKPI-NPYKDBGNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 678.78 | Molecular Weight (Monoisotopic): 678.3588 | AlogP: 1.89 | #Rotatable Bonds: 22 |
Polar Surface Area: 244.50 | Molecular Species: ACID | HBA: 11 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: -10.30 | CX Basic pKa: | CX LogP: 1.96 | CX LogD: 1.85 |
Aromatic Rings: 1 | Heavy Atoms: 48 | QED Weighted: 0.04 | Np Likeness Score: 0.71 |
1. Reddy PRS, Sambyal S, Mhamane TB, Sravanthi V, Shafi S, Khan IA, Sampath Kumar HM.. (2022) Synthesis and biological evaluation of novel 2-azido muramyl dipeptide as NOD2 agonistic adjuvants., 66 [PMID:35569249] [10.1016/j.bmc.2022.116781] |
Source(1):